Dresden University of Technology-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2015

  1. Elotuzumab therapy for relapsed or refractory multiple myeloma

    New England Journal of Medicine, Vol. 373, Núm. 7, pp. 621-631